A next-generation Eli Lilly weight-loss drug that hasn't even been submitted for Food and Drug Administration review is already spawning a rash of cheap knockoffs that are being...
Health insurers have spent the past year touting how they've cut pre-treatment review claims, but new data suggests that hasn't eliminated hurdles for patients and doctors.